Efavirenz for Patients With Alzheimer's Disease

Clinical trial NCT03706885 · COMPLETED

Trial details

NCT number: NCT03706885
Sponsor: Case Western Reserve University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease, Early Onset

Start date: 2018-05-05
Primary completion: 2022-01-28
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.